1 to 15 of 33
Sort by: Date | Relevance
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted Today
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted Today
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 1 day ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 2 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 3 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 3 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 7 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 7 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 8 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 15 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 15 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 15 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 15 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 16 days ago
About Affinivax Affinivax is a Cambridge based clinical stage biotechnology company with a novel, next generation approach to the development of vaccines and immunotherapies targeting infectious and other immune mediated diseases. This novel and highly efficient vaccine technology called Multiple Antigen Presenting System (MAPS) enables the high affinity binding of protec
Posted 17 days ago
Email this Job to Yourself or a Friend
Indicates required fields